IL2 and cancer: Furthermore, adoptive cell transfer (ACT) of orthogonal IL-2Rβ transduced effector CD4 + and CD8 + T cells resulted in elevated anti-tumor immune responses upon orthogonal IL-2 injection in a pre-clinical cancer model [119].